CoChat

Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program

Open access
Kim, Catherine, Dabelea, Dana, Kalyani, Rita R, Christophi, Costas A, Bray, George A, Pi-Sunyer, Xavier, Darwin, Christine H, Yalamanchi, Swaytha, Barrett-Connor, Elizabeth, Golden, Sherita Hill, Boyko, Edward J · 2017 · The Journal of Clinical Endocrinology & Metabolism
Cited by 54

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Context: The degree to which changes in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) relate to corresponding changes in plasma sex steroids is not known. Objective: We examined whether changes in VAT and SAT areas assessed by computed tomography were associated with changes in sex hormones [dehydroepiandrosterone sulfate (DHEAS), testosterone, estradiol, estrone, and sex hormone binding globulin (SHBG)] among Diabetes Prevention Program participants. Design: Secondary analysis of a randomized trial. Participants: Overweight and glucose-intolerant men (n = 246) and women (n = 309). Interventions: Intensive lifestyle change with goals of weight reduction and 150 min/wk of moderate intensity exercise or metformin administered 850 mg twice a day or placebo. Main Outcome Measures: Associations between changes in VAT, SAT, and sex hormone changes over 1 year. Results: Among men, reductions in VAT and SAT were both independently associated with significant increases in total testosterone and SHBG in fully adjusted models. Among women, reductions in VAT and SAT were both independently associated with increases in SHBG and associations with estrone differed by menopausal status. Associations were similar by race/ethnicity and by randomization arm. No significant associations were observed between change in fat depot with change in estradiol or DHEAS. Conclusions: Among overweight adults with impaired glucose intolerance, reductions in either VAT and SAT were associated with increased total testosterone in men and higher SHBG in men and women. Weight loss may affect sex hormone profiles via reductions in visceral and subcutaneous fat.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2017-00967

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Barrett-Connor, 2003, Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women, J Clin Endocrinol Metab, 88, 4031, 10.1210/jc.2003-030876 · DOI
  2. Mongraw-Chaffin, 2015, Association between sex hormones and adiposity: qualitative differences in women and men in the multi-ethnic study of atherosclerosis, J Clin Endocrinol Metab, 100, E596, 10.1210/jc.2014-2934 · DOI · Paper page
  3. Janssen, 2010, Testosterone and visceral fat in midlife women: the Study of Women’s Health Across the Nation (SWAN) fat patterning study, Obesity (Silver Spring), 18, 604, 10.1038/oby.2009.251 · DOI · Paper page
  4. Tepper, 2012, Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women’s Health across the Nation (SWAN), J Clin Endocrinol Metab, 97, 2872, 10.1210/jc.2012-1422 · DOI · Paper page
  5. Wildman, 2012, Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women’s Health Across the Nation, J Clin Endocrinol Metab, 97, E1695, 10.1210/jc.2012-1614 · DOI · Paper page
  6. Bray, 2008, Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program, Am J Clin Nutr, 87, 1212, 10.1093/ajcn/87.5.1212 · DOI · Paper page
  7. Fujimoto, 2007, Body size and shape changes and the risk of diabetes in the diabetes prevention program, Diabetes, 56, 1680, 10.2337/db07-0009 · DOI · Paper page
  8. Kim, 2016, Testosterone and depressive symptoms among men in the Diabetes Prevention Program, 63
  9. Kim, 2012, Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program, J Clin Endocrinol Metab, 97, 2853, 10.1210/jc.2012-1233 · DOI
  10. Kocarnik, 2016, Baseline estradiol concentration in community-dwelling Japanese American men is not associated with intra-abdominal fat accumulation over 10 years, Obes Res Clin Pract, 10, 624, 10.1016/j.orcp.2015.12.002 · DOI
  11. Nielsen, 2007, Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men, J Clin Endocrinol Metab, 92, 2696, 10.1210/jc.2006-1847 · DOI · Paper page
  12. Mather, 2015, Steroid sex hormones, sex hormone binding globulin, and diabetes incidence in the Diabetes Prevention Program, J Clin Endocrinol Metab, 100, 3778, 10.1210/jc.2015-2328 · DOI · Paper page
  13. Foster, 2012, Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location, Adipocyte, 1, 192, 10.4161/adip.21756 · DOI · Paper page
  14. Peter, 2010, Relationships of circulating sex hormone-binding globulin with metabolic traits in humans, Diabetes, 59, 3167, 10.2337/db10-0179 · DOI · Paper page
  15. Vermeulen, 1999, A critical evaluation of simple methods for the estimation of free testosterone in serum, J Clin Endocrinol Metab, 84, 3666, 10.1210/jcem.84.10.6079 · DOI · Paper page
  16. Cauley, 1991, Reliability and interrelations among serum sex hormones in postmenopausal women, Am J Epidemiol, 133, 50, 10.1093/oxfordjournals.aje.a115801 · DOI · Paper page
  17. Tsai, 2000, Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men, Int J Obes Relat Metab Disord, 24, 485, 10.1038/sj.ijo.0801183 · DOI · Paper page
  18. Dieudonne, 1998, Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids, Am J Physiol, 274, C1645, 10.1152/ajpcell.1998.274.6.C1645 · DOI · Paper page
  19. Dieudonne, 2000, Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2, Endocrinology, 141, 649, 10.1210/endo.141.2.7293 · DOI · Paper page
  20. Dieudonné, 2004, Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens, Am J Physiol Cell Physiol, 286, C655, 10.1152/ajpcell.00321.2003 · DOI · Paper page
  21. Grundy, 2013, Waist circumference as measure of abdominal fat compartments, J Obes, 2013, 454285, 10.1155/2013/454285 · DOI · Paper page
  22. Hankinson, 1995, Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period, Cancer Epidemiol Biomarkers Prev, 4, 649
  23. Kim, 2012, Racial/ethnic differences in sex hormone levels among postmenopausal women in the diabetes prevention program, J Clin Endocrinol Metab, 97, 4051, 10.1210/jc.2012-2117 · DOI · Paper page

Cited by

See all 54

Metadata

Authors
Kim, C., Dabelea, D., Kalyani, R. R., Christophi, C. A., Bray, G. A., Pi-Sunyer, X., Darwin, C. H., Yalamanchi, S., Barrett-Connor, E., Golden, S. H., & Boyko, E. J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-06-23
Volume
102
Issue
9
Pages
3381-3389
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2649770657
Cited by
54
References
9
FWCI
3.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.